Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Drugmakers place big bets on the emerging science of microRNA.
MIT professor shares an update about his work in cancer research at the Koch Institute.
The technique could help patients with currently untreatable diseases such as Huntington’s.
A newly made synthetic ribosome is an important step in the quest to create artificial life forms.
Researchers at the University of Texas Southwestern Medical Center have found that RNA may be a potential tool in activating dormant genes.
A biotech company founded by Craig Mello, codiscoverer of RNAi, brings its first self-delivering interfering RNA to clinical trial.
Repetitive stretches of RNA are found in high concentrations in cancer cells.
In first human trial, particles successfully reach cancer cells and silence the target gene.
A new drug suppresses the virus in chimps without generating resistance.